OIAM
MRNA icon

OFI Invest Asset Management’s Moderna MRNA Stock Holding History

OFI Invest Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.2M Buy
547,881
+547,583
+183,753% +$25.5M 0.32% 80
2025
Q4 		$7.48K Hold
298
– – ﹤0.01% 370
2025
Q3 		$6.55K Hold
298
– – ﹤0.01% 299
2025
Q2 		$7K Sell
298
-284
-49% -$7.48K ﹤0.01% 313
2025
Q1 		$15.3K Sell
582
-611
-51% -$21.7K ﹤0.01% 361
2024
Q4 		$47.9K Buy
+1,193
New +$57K ﹤0.01% 289
2024
Q2 		$132K Buy
1,193
+83
+7% +$10.5K ﹤0.01% 267
2024
Q1 		$110K Hold
1,110
– – ﹤0.01% 166
2023
Q4 		$99.9K Hold
1,110
– – ﹤0.01% 163
2023
Q3 		$108K Sell
1,110
-133,546
-99% -$14.9M ﹤0.01% 136
2023
Q2 		$16.3M Sell
134,656
-21,299,497
-99% -$2.84B 0.65% 53
2023
Q1 		$140M Buy
+21,434,153
New +$3.54B 0.72% 45

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return